Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Conavi Medical ( (TSE:CNVI) ).
Conavi Medical Corp. announced its participation in the Planet MicroCap Showcase: TORONTO 2025, where CEO Tom Looby will present the company’s advancements on October 22, 2025. This event highlights Conavi’s strategic efforts to engage with investors and stakeholders, potentially enhancing its market presence and attracting investment interest in its innovative cardiovascular imaging technologies.
The most recent analyst rating on (TSE:CNVI) stock is a Buy with a C$1.00 price target. To see the full list of analyst forecasts on Conavi Medical stock, see the TSE:CNVI Stock Forecast page.
More about Conavi Medical
Conavi Medical Corp. is a commercial-stage medical device company that focuses on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures. Their flagship product, the Novasight Hybrid™ System, uniquely combines intravascular ultrasound and optical coherence tomography for simultaneous imaging of coronary arteries. The system has regulatory clearance in the U.S., Canada, China, and Japan.
Average Trading Volume: 31,140
Technical Sentiment Signal: Sell
Current Market Cap: C$34.74M
See more data about CNVI stock on TipRanks’ Stock Analysis page.